| HS Code | 578240 |
| Iupac Name | 2-(2-(3-(2-(7-Chloroquinolin-2-yl)ethenyl)phenyl)-3-hydroxypropyl)phenyl)-2-propanol |
| Molecular Formula | C27H26ClNO2 |
| Molecular Weight | 431.96 g/mol |
| Appearance | Solid (exact color may vary) |
| Solubility | Soluble in organic solvents such as DMSO and ethanol |
| Structure Type | Aromatic and heterocyclic compound |
| Functional Groups | Alcohol, Alkene, Aromatic, Heterocycle |
| Chlorine Presence | Contains a chlorine atom |
| Quinoline Presence | Contains a quinoline ring |
| Hydroxyl Groups | Contains two hydroxyl (–OH) groups |
As an accredited 2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 25 grams, sealed with a PTFE-lined screw cap, labeled with chemical name, CAS number, and safety precautions. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL): Efficiently loads approximately 10-12 metric tons of 2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol, securely packed in drums or bags. |
| Shipping | This chemical, **2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol**, is shipped in accordance with all relevant regulations. Packaging ensures protection from moisture and light, using sealed containers and secondary containment. Hazard labeling and documentation are provided. Temperature-controlled shipping is available if required. Only trained personnel handle and transport the material. |
| Storage | Store **2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol** in a tightly sealed container, protected from light and moisture, at 2–8°C (refrigeration). Keep away from strong oxidizing agents and incompatible substances. Ensure storage is in a well-ventilated, cool, and dry area. Label container clearly and handle according to standard laboratory safety procedures for potentially hazardous chemicals. |
| Shelf Life | Shelf life: Typically 2–3 years when stored in a cool, dry place, protected from light and moisture, in tightly sealed containers. |
Our proprietary synthesis of 2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol positions this molecule in highly specialized downstream processes that demand tailored molecular architecture and reliable supply consistency. Below, we outline targeted application segments based on validated industrial practices.
Pharmaceutical manufacturers utilize this compound as a critical intermediate in producing novel antimalarial molecules, including analogues of chloroquine-resistant treatments. The unique quinoline structure permits direct integration into synthesis routes that improve pharmacokinetics and bioavailability. Key process stages include hydrogenation, cross-coupling, and enantioselective modifications conducted in cGMP-validated environments. The intermediate’s reactivity supports the formation of advanced salt forms, ensuring high-purity final APIs for regulated markets.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Leading crop protection companies employ this molecule for its tailored quinolinyl functionalization in the synthesis of pre- and post-emergent herbicides. Its high reactivity profile supports multi-step construction of actives with improved selectivity and environmental fate. Typical application involves its direct coupling to halogenated rings or etherified chains, delivering desirable residual activity. Quality assurance teams monitor residual solvent and by-product profiles to comply with stringent agrochemical registration requirements.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Producers of industrial coatings incorporate this hydroxypropyl quinolinyl compound as a chain extender and reactive modifier within polyurethane and acrylic matrices. The molecular design enhances UV resistance, chemical durability, and crosslink density, leading to superior weathering performance. Batch production adheres to real-time monitoring of molecular weight distribution to assure compatibility with automotive and heavy-duty industrial applications requiring minimal VOC emissions.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Manufacturers specializing in diagnostic imaging and analytical chemistry utilize this compound as a scaffold for quinolinyl-based fluorescent dye synthesis. The presence of hydroxy and alkene functionalities enables site-specific derivatization, forming high-brightness probes with narrow emission spectra. Application-specific purification and analytical characterization, including LC-MS and fluorescence quantum yield validation, ensure suitability for regulated research and clinical environments.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Producers of specialty adhesives exploit the reactivity of this raw material to engineer unique hardening characteristics and improve substrate bonding primarily in aerospace and electronics assemblies. The compound’s propanol and hydroxypropyl groups facilitate covalent interaction with epoxy and cyanoacrylate matrices, increasing cohesive strength and heat resistance. Real-time control of gel time and tensile shear limits batch variability, aligned with high-reliability application standards.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive 2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Our years of experience in custom chemical synthesis have led us to focus more of our work on specialty quinoline-based compounds. Among these, 2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol stands out for its steady performance in specific pharmaceutical and high-value chemical applications. We recognized early on that the pharmaceutical industry’s expectation for purity isn’t just a number—it’s a threshold deciding real-world yield and downstream reaction reliability. So, every batch of this compound comes free from residues common to similar synthetic routes.
During production, we manage every stage from raw chlorine and quinoline sourcing up to final purification under strict controls. Most competitors purchase partial intermediates, which leaves quality susceptible to outside variability. By keeping the entire process in-house, we maintain control over every factor—from the timing of the ethenyl group introduction to the temperature slope during the propylation step. That has demonstrably reduced batch rejection rates compared to the industry average.
We produce this compound with assay levels consistently above 99%. Rigorous HPLC and NMR checks confirm structural integrity batch after batch. Experienced researchers visiting our facility often focus on the impurity profile rather than just assay numbers. From practical standpoint, the difference between 99.0% and 99.2% can mean another round of column purification off their tables, saving hours in research and manufacturing. Moisture picks up fast on quinoline rings, so we finish with comprehensive Karl Fischer, always aiming to keep water below 0.05% w/w.
Particle size distribution emerges from direct communication with our customers; labs working on active intermediates for anti-malarial agents report fewer complications in scale-up reactions when we control the crystallization step within a tighter window. Average particle diameter typically sits below 60 microns based on feedback, striking a balance between filterability in downstream synthesis and optimal reactivity.
We package under nitrogen and double-wrap polyethylene liners inside fiber drums. The odor noticed by people handling open drums mainly belongs to the quinoline core, not excess chloro byproducts—one benefit of keeping byproduct formation to a strict minimum.
Over the last decade, industry partners increasingly ask where materials, precursors, and even solvents originate. Traceability is more than a check-box; it tracks every step of synthesis and allows prompt action if a deviation surfaces. Several years ago, an upstream supplier delivered a solvent batch that introduced a stubborn peak in the GC-MS scan. Because we document reactant lot numbers from start to finish, we pinpointed and resolved the source quickly, a fix invisible in commodity trading but critical for sensitive products.
In pharmaceutical syntheses, single-digit ppm contamination from unreacted starting material forces entire campaigns back to reprocessing. Most third-party distributors simply pass along certificates, but as the manufacturer, our own team of analysts has full auditability from stockroom to shipment. We have learned to assign chemists to cross-check lots outside their direct work groups, helping spot minute inconsistencies not flagged by machines alone.
Lab reality often doesn’t match the idealized data sheet. Manufacturing for nearly twenty years, we have seen countless projects delayed because of subtle process drift. A slight variation in the enolization step changes reactivity in subsequent reactions, even when classical assay values look identical. That experience drove us to invest heavily in both process automation and human review. The complex structure of this compound—linking a chloroquinoline moiety with a hydroxypropyl-bridged, ethenyl-substituted phenyl—offers multiple sites for missteps. We train technicians to recognize not only standard color changes but also the sharp, transient odor of hydroxypropyl intermediates. No trading company commits to this level of process scrutiny.
Customer trials showed us the true value of consistency. A client scaling a selective cyclization reaction reported that spikes in trace impurities dramatically altered yield across batches from other sources. After six months of routine supply from our plant, they achieved batch-to-batch variation under 1.5%, which let them optimize their downstream steps further. Prior to this, even minor changes in byproduct levels had forced them into defensive process engineering.
Customers use this compound primarily in drug discovery efforts involving kinase inhibition and anti-infective development. Its structure, with a unique juxtaposition of quinoline and vinyl-phenyl rings linked through a hydroxypropyl chain, provides a robust scaffold for substitution reactions. Chemists aiming to tweak bioactivity find this backbone versatile, with common modifications at both alcohol groups and aromatic sites.
Our own collaborations with researchers confirmed the structure’s amenability to selective functionalization. In one project, a customer attached a sulfonyl group onto the quinoline nitrogen while simultaneously alkylating the terminal alcohol. The robustness of our product—free of unreacted halo intermediates—gave them consistent chemistry yields not possible with less-refined equivalents. Years of activity screening found this backbone particularly persistent in cell-based assays, avoiding interference from oxidative breakdown typically seen with related compounds.
Beyond pharma, this molecule grows increasingly significant in advanced material research. Surface modification of polymers by using the hydroxy functionality yielded stable coatings, resistant to UV degradation. Such work only moves forward with a clean, well-characterized reagent; even trace metal contamination would change surface wetting and light absorption. Our practice of monitoring metals down to low ppb levels (primarily palladium, platinum, and iron) has supported several academic consortia pursuing organic electronics and photonic materials.
As a direct manufacturer, comparison happens every day—sometimes inside our own shift handoff meetings, more often as feedback from global customers working with competing sources. Many alternative suppliers rely on a simplified one-pot method to string together the quinoline and phenyl units. This typically leaves a mix of regioisomers and contaminating dimers. Our approach involves staged reactions, segregation and purification at every key step, and repeated re-crystallization before secondary alcohol introduction.
We knew from early batches that speed at the expense of selectivity spells trouble for scale-up. By controlling the introduction order—synthesizing the chlorinated quinoline first, then engaging in the protected vinylation of the phenyl unit before hydroxypropylation—we sidestep the buildup of byproducts and resinous tars often found in shortcut processes. Analytical data prove our method produces purer end material. What that means in practice: less time spent by customers troubleshooting their own purifications, and less variability in their finished products.
The difference from distributor-provided material often becomes clear as customers proceed through months of scale-up. In one illustrative case, a pilot plant using our competitor’s compound faced regular glassware fouling and filtration blockages. With our material, based on the same reaction route but tightly controlled, these issues disappeared, and not a single batch required unplanned intervention over a full production quarter.
Residual solvent content forms another key difference. Many producers allow up to 0.5% of DMF or toluene in the final product, leading to headaches during late-stage syntheses. Our in-plant headspace GC measurements keep residual solvents well below 0.1%, a win for both downstream safety and toxicology risk management.
Meeting regulatory and quality standards has risen sharply in importance. Regulatory agencies demand documentation not just on product identity, but every step and input involved in the synthesis. In our direct experience, the only reliable way to ensure such compliance comes from holding every lever yourself. Every lot we dispatch gets matched against an indexed synthesis batch record, raw material supply chain audit, and final analytical summary.
Distribution channels sourced through traders can create long waiting times for simple quality clarifications. By communicating directly with the research chemist or process tech, we answer questions about precursors, barcode history, or process solvents within hours. Several major customers told us the reduced communication lag saved them from project delays and expensive revalidation.
Custom documentation also matters. Investigational drug applications require signed, original analytical records. By integrating analytical services under our roof, we prepare and retain these records with full chain-of-custody logs. We remember a project where a third-party auditor questioned peak identity on a supplied chromatogram; because our process chemist could present primary data, regulatory acceptance proceeded smoothly. That only happens when the manufacturer assumes full accountability.
Scaling production to multi-kilogram volumes required learning the art of balancing reactivity, safety, and environmental stewardship. Early on, effluent streams from the chloro-group introduction step resulted in persistent odor and regulatory inspection. Rather than masking the problem, we invested in condenser upgrades and secondary containment. This change improved air quality for workers and kept emissions well below set thresholds—earning repeat environmental certification audits in the process.
Maintaining process reproducibility as scale increases takes both vigilance and investment. We have established a technical knowledge transfer loop between lab, pilot, and full-scale reactors. Process engineers review runs from start to finish with manufacturing chemists, exchanging data on yield, impurity evolution, and energy usage. Through this approach, even as volumes grow, we protect the same quality and batch-to-batch predictability.
Supply chain stability for rare building blocks sets itself as an ongoing challenge. Shortages in the global supply of chlorinated quinoline can drive up lead times. Years of supplier vetting let us establish parallel sources and buffer inventories. Periodic disruptions inevitably occur, but robust relationships and in-house intermediate synthesis give our partners confidence they won’t face unexpected outages.
Practical feedback from users provides our strongest guidepost. One pharmaceutical company transitioned all exploratory syntheses to use our product following several months of inconsistent results with material from resellers. They reported both improved yields and higher confidence in bioassay outcomes—a testament to reducing background interference from invisible impurities. Their experience underscores our belief: an apparently minor issue at the batch level can become the deciding factor in experimental repeatability.
Academic users bring different priorities. For groups exploring new analogs or reaction mechanisms, minimal baseline noise and peak clarity speed their screening work. We field dozens of method-development requests each quarter, making slight process modifications to support new reaction routes.
It always comes back to partnership. We welcome direct dialogue with those who use our compound, whether to troubleshoot an unexpected result or to brainstorm next-generation applications. This ongoing feedback loop shapes our focus on both incremental and breakthrough improvements. Longevity in this field doesn’t come from a static product list—it grows from adapting to real research demands, learning from failures, and closing gaps that disrupt discovery.
Others may focus on cost, but as the direct producer we see reputation and performance as inseparable. The standard we hold ourselves to exceeds regulatory minimums because we know each bottle, drum, or bag opens in front of a chemist or engineer whose own results depend on our work. By controlling every input and output, by listening carefully to the sometimes unexpected needs of advanced researchers, and by refusing to take shortcuts—this is how we have built lasting trust in the advanced quinoline derivative sector.
To those partners, current and future, we offer more than a product. We offer shared expertise, deep transparency, and a commitment to fixing problems—not just celebrating successes. That approach has drawn both industry leaders and fresh innovators to collaborate with us at every stage, from synthesis design to scale-up and application. With each batch of 2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol shipped, we reinforce a network of trust built one reaction at a time. The science moves forward, and we are proud to be an active participant, not simply a bystander in the chain.